Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by IrishCanuckon Nov 10, 2020 10:49am
68 Views
Post# 31869971

RE:RE:More on the Sweetwater deal

RE:RE:More on the Sweetwater dealWelcome back Stretch lol I addressed all your concerns as you brought them up, but I can see you are still thin skinned. You need to work on your elementary school name calling if that's your calling card on here

Everything you are touting is misdirection. Canopy has licenses for Canada yes, but Canopy does not acquire Acreage's "licenses" (read: dispensaries) until weed is federally legal in the US at which time they are irrelevant. You are touting yet another overpay Canopy has done

Aphria can sell CBD products at any time if THC content is below 0.3% content and derived for hemp. This is why Sweetwater is beneficial in Canada and US. Sweetwater is the plan you claim to not see. Any other concern you claim Canopy has an advantage over Aphria does not come to fruition until minimum 2-3 years from now

Until the American legal system infrastructure is in place, Aphria does not need to tie themselves down to a business model that may not be optimal before then. Aphria is the safest bet as it is profitable today and does not rely on hype... or overly aggress posts on Stockhouse from some retail investor...  
<< Previous
Bullboard Posts
Next >>